The role of drug regulatory authorities and health technology assessment agencies in shaping incentives for antibiotic R&D: a qualitative study
Abstract Background Few antibiotics have entered the market in recent years despite the need for new treatment options. Some of the challenges of bringing new antibiotics to market are linked to the marketing authorization and health technology assessment (HTA) processes. Research shows great variat...
Main Authors: | Cecilia Kållberg, Liv Mathiesen, Unni Gopinathan, Hege Salvesen Blix |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-03-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40545-023-00556-x |
Similar Items
-
Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities
by: Lorraine Danks, et al.
Published: (2023-10-01) -
Examining the Legal Standing of IKN Authority Regulations within Indonesian’s Legislation System
by: Harry Setya Nugraha, et al.
Published: (2023-12-01) -
The President of the Energy Regulatory Authority in relation to energy policy in Poland
by: Marcin Rejmus
Published: (2014-06-01) -
The Analysis of the Regulatory Activity of Executive Authorities
by: Kolupaieva Irina V.
Published: (2018-03-01) -
Impact of Antibiotic Authorisation at Three Provincial Hospitals in Thailand: Results from a Quasi-Experimental Study
by: Walaiporn Wangchinda, et al.
Published: (2022-03-01)